Pfizer Inc's anti-blood clotting drug Fragmin effectively prevents blood clots in cancer patients. This was stated by a United States advisory panel who believes that the drug warrants further approval. Fragmin is sold for treating clots in various surgical patients. Chemotherapy patients can be prone to blood clots, caused by intravenous lines or the drugs themselves.
A single study showed that patients taking Fragmin had fewer patients experience blood clots. The FDA does have concerns but they usually follow the advice of its advisory panels.
Blood clots can become harmful when they block an artery or vein to stop blood flow. Some symptoms could be pain in the calf or leg muscle, swelling, tenderness, discoloration, or prominent veins.
If you need additional information on blood clots and the currant therapies available you can go to Chemocare.com.
